StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Equities research analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a note issued to investors on Wednesday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

NYSE:AMPE opened at $0.00 on Wednesday. The firm has a market cap of $2,394.00, a PE ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $2.47. The company’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.01.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.